Our Therapeutic
Areas of Focus
Powered by
TGF-ß science,
inspired by
patients
At Keros, our mission is to innovate therapies
that have the potential to shift the treatment
paradigm for a wide range of patients with
disorders that are linked to dysfunctional
signaling of the transforming growth
factor-beta (TGF-ß) family of proteins.
News
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
November 6, 2024
Read MoreKeros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
November 6, 2024
Read MoreKeros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition
November 5, 2024
Read More
Our Therapeutic
Advancing Novel Therapeutics With a Focus on Cellular Growth & Repair
The transforming growth factor-beta (TGF-β) superfamily is a group of regulatory proteins that is key to the growth, repair and maintenance of blood cells and a number of tissues. Leveraging our deep expertise in TGF-β science, we are focused on developing and commercializing novel therapeutics with the ability to modulate TGF-β signaling and unlock potentially disease-modifying benefits for patients in need.
Working at Keros is More Than
A Job - It's A Mission
What Drives Us
We take our mission personally.
We love our work.
It’s about the science.
We invest in our people.